Filtered By:
Cancer: Thyroid Cancer
Drug: Lithium

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Downregulation of vascular endothelial growth factor receptor-2 under oxidative stress conditions is mediated by β-transduction repeat-containing protein via glycogen synthase kinase-3β signaling.
Abstract Vascular endothelial growth factor receptor-2 (VEGFR-2), which is a key determinant of the angiogenecic response, is decreased in diabetic mice under oxidative stress. β-transduction repeat-containing protein (β-TrCP) has been reported to participate in VEGFR-2 degradation in thyroid cancer cells. Additionally, glycogen synthase kinase-3β (GSK‑3β) acts as a mediator in the β-TrCP-induced degradation of several proteins. However, the role played by β-TrCP and GSK‑3β in the degradation of VEGFR-2 in endothelial cells where hyperglycemia had been induced was not fully understood. In the present ...
Source: International Journal of Molecular Medicine - February 18, 2016 Category: Molecular Biology Authors: Wu W, Zhang D, Pan D, Zuo G, Ren X, Chen S Tags: Int J Mol Med Source Type: research